Folate intake in Europe: Recommended, actual and desired intake

European Journal of Clinical Nutrition

Volumn 51, Issue 10, 1997, Pages 643-660

  De Bree, A ^a,b   Van Dusseldorp, M ^a   Brouwer, I A ^a,c   Van Het Hof, K H ^b   Steegers Theunissen, R P M ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Folic acid administration and dosage; Folic acid requirements; Homocysteine blood; Neural tube defects prevention and control, review; Nutrition surveys

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CEREAL; DIET SUPPLEMENTATION; DIETARY INTAKE; EUROPE; FOOD INTAKE; FRUIT; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; REVIEW; RISK FACTOR; VEGETABLE;

EID: 0030695338     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600467     Document Type: Review

References (112)

1. Adolf T, Eberhardt W, Heseker H, Hartmann S, Herwig A, Matiaske B, Moch KJ, Schneider R & Kübler W (1994): VERA-Schriftenreihe, Bank XII. Ergänzungsband zum Ernärungsbericht 1992, eds. W. Kübler, HJ Anders & W Heeschen. Giessen: Offset Köhler KG.
2. Adolf T, Schneider R, Eberhardt W, Hartmann S, Herwig A, Heseker H, Hünchen K, Kübler W, Matiaske B, Moch KJ & Rosenbauer J (1995): VERA-Schriftenreihe, Band XI. Ergebnisse der Nationalen Verzehrsstudie (1985-1988) über die Lebensmittel-und Nährstoffaufnahme in der Bundesrepublik Deutschland, eds. W Kübler, HJ Anders & W Heeschen, Giessen: Offset Köhler KG.
3. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH & Nordrehaug JE (1995): Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 24, 704-709
4. Andersen NL, Fagt S, Groth MV, Hartkopp HB, Moller A, Ovesen L & Warming DL (1996): Danskernes kostvaner 1995. Sundhedsministeriet. Saborg: Levnedsmiddelstyrelsen.
5. Bailey LB (1995): Folate requirements and dietary recommendations. In Folate in Health and Disease, ed. LB Bailey, pp 123-115. New York: Marcel Dekker, Inc.
6. Banerjee DK, Maitra A, Basu AK & Chatterjea JB (1975): Minimal daily requirements of folic acid in normal Indian subjects. Indian J. Med. Res. 63, 45-53.
7. Bausch-Goldbohm RA, Hulshof KFAM, Brants HAM, Berg van den H & Bouman M (1995): De inneming van foliumzuur door verschillende bevolkingsgroepen in Nederland voor en na verrijking van bepaalde voedingsmiddelen. Voedselconsumptiepeiling 1992. TNO report V95.84. Zeist, The Netherlands: TNO Nutrition and Food Research Institute.
8. Becker WB (1992): Befolkningens kostvanor och näringsintag. Vår Föda. 8, 349-362.
9. Black AE, Paul AA & Hall C (1985): Footnotes to food tables 2. The underestimation of intakes of lesser B vitamins by pregnant and lactating women as calculated using the forth edition of McCance and Widdowson's 'The composition of foods'. Hum. Nutr. Appl. Nutr. 39A, 19-22.
10. Botez MI & Reynolds EH eds (1979): Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York: Raven Press.
11. Boushey CJ, Beresford SAA, Omen GS & Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 274, 1049-1057.
12. Bower C & Stanley FJ (1989): Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med. J. Australia. 150, 613-619
13. Brattström LE, Israelsson B, Jeppsson JO & Hultberg BL (1988): Folic acid - an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest. 48, 215-221.
14. Butterworth CE, Tamura T (1989): Folic acid safety and toxicity: a brief review. Am. J. Clin. Nutr. 50, 353-358.
15. CDC (Centers for Disease Control and Prevention) (1991): Use of folic acid for prevention of spina bifida and other neural tube defects 1983-1991. MMWR 40, 513-516.
16. Coelho CND, Weber JA, Klein NW, Daniels WG & Hoagland TA (1989): Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J. Nutr. 119, 1716-1725.
17. Cooper BA (1978): Reassessment of folic acid requirements. In Nutrition in Transition: Proceedings of the Western Hemisphere Congress No 5,eds. P. White P & N Selvey, pp 281-288. Monroe, WI: American Medical Association.
18. Colman N (1982): Addition of folic acid to staple food as a selective nutrition intervention study. Nutr. Rev. 40, 225-233.
19. Cuskelly GJ, McMulty H & Scott JM (1996): Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet. 347, 657-659.
20. Czeizel AE & Dudás I (1992): Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327, 1832-1835.
21. Den Heijer M, Brouwer IA, Blom HJ, Gerrits WBJ & Bos GMJ (1995): Lowering of homocysteine blood levels by means of vitamin supplementation. Ir. J. Med. Sci. 164(suppl 15), 7 (Abstract).
22. Dierkes J (1995): Vitamin requirement for the reduction of homocysteine blood levels in healthy young women. PhD thesis, University of Bonn, Germany.
23. DGE (Deutsche Gesellschaft für Ernährung) (1991): Empfelungen für die Nährstoffzufuhr, 5th edn. Frankfurt.
24. DH (Department of Health) Committee on Medical Aspects of Food Policy (1991): Report on Health and Social Subjects, 41. Dietary reference values for food energy and nutrients for the United Kingdom. London: HMSO.
25. DHHS/PHS (Department of Health and Human Services, Public Health Service) (1992): Recommendations of the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR:41 (RR-14), 1-7.
26. Dickinson CJ (1995): Does folic acid harm people with vitamin B12 deficiency? Q. J. Med. 88, 357-364.
27. DNHW (Department of National Health and Welfare) (1977): Food consumption patterns report. Ottawa
28. Dupin H, Abraham J & Biachetti I (1992): Apports Nutritionels Conseilles pour la Population Française,2nd edn. Technique et Documentation. Paris: Lavoisier.
29. EAG (Export Advisory Group) (1992): Folic Acid and the Prevention of Neural Tube Defects. London: Department of Health.
30. Engelhardt R & Gregory III JF 1990: Adequacy of enzymatic deconjugation in quantification of folate in foods. J. Agr. Food Chem. 38, 154-158.
31. FAO/WHO (1970): Requirements of Ascorbic Acid, Vitamin D, Vitamin B12, Folate and Iron. WHO technical report series no 452. Geneva: WHO.
32. FAO/WHO (1988): Requirements of Vitamin A, Iron, Folate and Vitamin B12. Report on a Joint FAO/WHO Expert Consultation. Food and Nutrition series. Rome: FAO.
33. FDA (Food and Drug Administration) (1994): Notice. Food labelling: Health claims and label statements; Folate and neural tube defects. Fed. Regist. 59, 433-436.
34. Finkelstein JD (1990): Methionine metabolism in mammals. J. Nutr. Biochem. 1990: 1, 228-237.
35. FNC (Food and Nutrition Council) (1992a): Nederlandse Voedingsnormen 1989. The Hague: Voorlichtingsbureau voor de voeding.
36. FNC (Food and Nutrition Council) (1992b): Report on the Relationship Between Folic Acid Intake and Neural-Tube Defects. The Hague: Voorlichtingsbureau voor de voeding.
37. Friel JK, Frecker M & Fraser FC (1995): Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am. J. Med. Genet 55, 195-199.
38. Gailani SD, Carey RW, Holland JF & O'Malley JA (1970): Studies of folate deficiency in patients with neoplastic disease Cancer Res. 30, 327-333.
39. Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ & Malinow R (1991): Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Arterioscler. Thromb. 11, 1129-1136.
40. Giles WH, Kittner SJ, Anda RF, Croft JB & Casper ML (1995): Serum folate and risk for Ischemic stroke. First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Stroke. 1995: 26, 1166-1170.
41. Giovannucci E, Stampfer M, Colditz G, Rimm E, Trichopolous D, Rosner B, Speizer F & Willett W (1993): Folate, methionine, and alcohol intake and risk of colorectal adenoma. J. Natl. Cancer Inst. 85, 875-884.
42. Green R & Jacobsen DW (1995): Clinical implications of hyperhomocysteinemia. In Folate in Health and Disease, ed. LB Bailey, pp 75-122. New York: Marcel Dekker, Inc.
43. Gregory III JF (1989):Chemical and nutritional aspects of folate research: Analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv. Food Nutr. Res. 33, 1-101.
44. Gregory III JF, Engelhardt R, Bhandari SD, Sartain DB & Gustafson SK 1990: Adequacy of extraction techniques for determination of folate in foods and other biological materials. J. Food Comp. Anal. 3, 1-11.
45. Gregory III JF (1995): The bioavailability of folate. In Folate in Health and Disease, ed. LB Bailey pp 195-236. New York: Marcel Dekker, Inc.
46. Gregory J. Foster K, Tyler H & Wiseman M (1990): The Dietary and Nutritional Survey of British Adults.Office of population and surveys. London: HMSO.
47. a parte). Lisboa: Instituto Nacional de Saúde Dr. Ricardo Jorge.
48. Hall CA & Chu RC (1990): Serum homocysteine in routine evaluation of potential vitamin B12 and folate deficiency. Eur. J. Haematol 45, 143-149.
49. Hansen H & Rybo G (1967): Folic acid dosage in prophylactic treatment during pregnancy. Acta Obst. Gyn. Scand. 46 (suppl 7), 107-112.
50. HC/FNC (Health Council/Food and Nutrition Council) (1993): Follow-up Report on the Relationship Between Folic Acid Intake and Neural Tube Defects. The Hague.
51. Herbert V 1962a: Minimal daily adult requirement. Arch. Int. Med. 110, 649-652.
52. Herbert V 1962b: Experimental nutritional folate deficiency in man. Trans. Assoc. Amer. Phys. 75, 307-320.
53. Herbert V 1963: Current concepts in therapy - megaloblastic anaemia. N. Engl. J. Med. 201, 368-371.
54. Herbert V (1977): Folic acid requirements in adults (including pregnant and lactating females). In Folic Acid. Biochemistry and Physiology in Relation to the Human Requirement, ed. J. Lindenbaum, pp 247-255. Washington DC: National Academy of Sciences.
55. Herbeth B, Potier de Courcy G, Sancho J, Bourgeay-Causse M. Carre-Guery G, Chau N, Delacoux E, Le Devehat, Lemoine A, Mareschi JP, Miracet L & Zittoun 1985: JESVITAF. Survey on the vitamin status of the French: Relationship between nutrient intake and biochemical indicators. Acta. Vitaminol. Enzymol. 7, 207-216.
56. Hercberg S, Galan P & Dupin H (1990): Aspects Actuels des Carences en fer et en Folates dans le Monde. Paris: INSERM
57. Hercberg S, Preziosi P, Galan P, Devanlay M, Keller H, Bourgeois C, Potier de Courcy G & Cherouvrier F 1993: Vitamin status of a healthy French population: dietary intakes and biochemical markers. Int. J. Vit. Nutr. Res. 64, 220-232.
58. Hibbard ED & Smithells RW 1965: Folic acid metabolism and human embryopathy. Lancet. i, 1254-1256.
59. Holland B, Welch AA, Undin JD, Buss DH, Paul AA & Southgate DAT(1991): McCance and Widdowson's: The Composition of Foods,5th edn. Cambridge: The Royal Society of Chemistry.
60. Hoppner K, Lampi B & smith DC (1977): Data on folacin activity in foods: availability, applications and limitations. In Folic Acid. Biochemistry and Physiology in Relation to the Human Nutrition Requirement, ed. J. Lindenbaum, pp 69-81. Washington DC: National Academy of Sciences.
61. Hoppner K & Lampi B (1980): Folate levels in human liver form autopsies in Canada. Am. J. Clin. Nutr. 33, 862-864.
62. Hurdle ADF, Borton D & Searles IH (1968): A method for measuring folate and its application to a hospital diet. Am. J. Clin. Nutr. 21, 1202-1207.
63. Jacob RA, WU M, Henning SM & Swendseid ME (1994): Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J. Nutr. 124, 1072-1080.
64. Kirke PN, Daly LE & Elwood JH (1992): A randomized trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch. Dis. Child. 67, 1442-1446.
65. Kushi LH, Lenart EB & Willett WC (1995): Health implications of Mediterranean diets in light of contemporary knowledge. 1 Plant foods and dairy products. Am. J. Clin. Nutr. 61(6 suppl), 1407S-1415S.
66. Laurence KM, James N, Miller MH, Tennant GB & Campbell H (1981): Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 282, 1509-1511.
67. Lee P & Cunningham K (1990): Irish National Nutrition Survey. Dublin: The Irish Nutrition & Dietetic Institute.
68. Lemoine A, Le Devehat C, Herbeth B, Bourgeay-Causse M, Delacoux E, Mareshi JP, Martin JY, Miravet L, Potier de Courcy G & Zittoun J (1986): Enquete sur le statut vitaminique de trois groups d'adultes francais. Ann. Nutr. Metab. 30 suppl 1.
69. Mason JB (1995): Folate status: Effects on carcinogenesis. In Folate in Health and Disease, ed. LB Bailey, pp 329-360. New York: Marcel Dekker, Inc.
70. McNulty H, McPartlin JM, Weir DG & Scott JM (1987): Folate catabolism in normal subjects. Hum. Nutr. Appl. Nutr. 41A, 338-341.
71. McNulty H (1995): Folate requirements for health in different population groups. Br. J. Biomed. Sci. 52, 110-119.
72. Milne DB, Johnson JR, Mahalko JR & Sandstead (1983): Folate status of adult males living in a metabolic unit: possible relationships with iron nuriture. Am. J. Clin. Nutr. 37, 768-773.
73. Mills L, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Walden ME, Depp OR & Hoffman HJ (1989): The absence of a relation between the periconceptional use of vitamins and neural tube defects. N. Engl. J. Med. 321, 430-435.
74. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG & Scott JM (1995): Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 345, 149-151.
75. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ & Willett W (1989): Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262, 2847-2852.
76. Morrison HI, Schaubel D, Desmeules M & Wigle DT (1996): Serum folate and risk of fatal coronary heart disease. JAMA 275, 1893-1896.
77. MRC Vitamin Study Research Group (1991): Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet. 338, 131-137.
78. Mulinare J, Cordero JF, Erickson JD & Berry RJ (1988): Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260, 3141-3145.
79. NRC (National Research Council) (1989): Recommended Dietary Allowances, 10th edn. Washington DC: National Academy Press.
80. O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ & Gregory, JF III (1995): Controlled dietary folate affects folate status in nonpregnant women. J. Nutr. 152, 2717-2725.
81. Passmore R & Eastwood MAeds. (1986): Davidson and Passmore Human Nutrition and Dieteticspp 161-163. New York: Churchill Livingstone.
82. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM & Shaper AG (1995): Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346, 1395-1398.
83. Picciano MF, Green T & O'Connor (1994): The folate status of women and health. Nutrition Today 29, 20-29.
84. Potier de Courcy G & Zittoun J (1990): Acide folique. InReferences en biologie Clinique, eds G Siest, J Henny & F Schiele, pp 57-66. Paris: Elsevier.
85. Rodriquez MS (1978):A conspectus of research on folacin requirements in man. J. Nutr. 102, 909-968.
86. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL & Taylor PC (1987): Folate requirement and metabolism in nonpregnant women. Am. J. Clin. Nutr. 46, 1016-1028.
87. Sauberlich HE (1995): Folate status of U.S. populations groups. In: Folate in Health and Disease, ed. LB Bailey, pp 171-194. New York: Marcel Dekker, Inc.
88. Scott JM, Weir DG & Kirke PN (1995): Folate and neural tube defects. In Folate in Health and Disease, ed. LB Bailey, pp 329-360. New York: Marcel Dekker, Inc.
89. Selhub J, Jacques PF, Wilson PWF, Rush D & Rosenberg IH (1993): Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693-2727.
90. Senti FR & Pilcheds (1984): Assessment of the Folate Nutritional Status of the U.S. Population Based on data Collected in the Second National Health and Nutrition Examination Survey, 1976-1980. Bethesda: Life Sciences Research Office, Federation of American Societies for Experimental Biology.
91. Serra Majem L, Ribas Barba L, Garcia Closas R, Ballart JF & Guayta Escolier R (1996): Libre Blanc: Avaluació de l'estat nutricional de la població catalana (1992-93): Avaluació dels hàbits alimentaris, el consum d'aliments, energia i nutrients, i de l'estat nutricional mitjançant indicadors bioquímics i antropomètrics Barcelona: Generalidad de Catalunya.
92. Shaw GM, Scaffer D, Velie EM, Morland K & Harris JA (1995): Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6, 219-226.
93. Smithells RW, Nevin NC, Seller MJ, Sheppard S, Harris R, Read AP, Fielding DW, Walker S, Schorah CJ & Wild J (1983): Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1, 1027-1031.
94. Stampfer MJ & Willett WC (1993): Homocysteine and marginal vitamin deficiency. The importance of adequate vitamin intake. JAMA 270, 2727.
95. Stampfer MJ & Rimm EB (1996): Folate and cardiovascular disease. Why we need a trial now. JAMA 275, 1929-1930.
96. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM & Eskes TKAB (1991): Neural-tube defects and derangement of homocysteine metabolism (letter). N. Engl. J. Med. 1991: 324, 199-200.
97. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ & Eskes TKAB (1994): Maternal hyperhomocysteinemia: A risk factor for neural tube defects? Metabolism 12, 1475-1480.
98. Tamura T, Buehring KU & Stokstad ELR (1972a): Enzymatic hydrolysis of pteroylpolyglutamates in cabbage. Proc. Soc. Exp. Biol. Med. 141, 1022-1025.
99. Tamura T, Shin YS, Williams MA & Stokstad ELR (1972b): Lactobacillus casei response to pteroylpolyglutamates. Anal. Biochem. 49, 517-521.
100. Taylor LM, De Frang RD, Harris EJ & Porter JM (1991): The association of elevated plasma homocysteine with progression of symptomatic peripheral vascular disease. J. Vasc. Surg. 13, 128-136.
101. Truswell AS, Irwin T, Beton GH, Suzue R, Haenel H, Hedja S, Hou XC, Leveille G, Morava E, Pedersen J & Stephen JML (1983): Recommended dietary intakes around the world. A report by Committee 1/5 of the International Union of Nutritional Sciences. Nutr. Abstr. Rev. 53, 939-1016.
102. Ubbink JB, Vermaak WJH, Merve van der A & Becker PJ (1993a): Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am. J. Clin, Nutr. 57, 47-53.
103. Ubbink JB, Merve van der A, Vermaak WJH & Delport R (1993b): Hyperhomocysteinimia and the response to vitamin supplementation. Clin. Invest. 71, 993-998.
104. Ubbink JB, Vermaak WJH, Merwe van der A, Becker PJ, Delport R & Potgieter HC (1994): Vitamin requirements for the treatment of hyperhomocysteinemia. J. Nutr. 124, 1927-1933.
105. Vergel RG, Sanchez LZ, Hededero BL, Rodriguez PRL & Martines AJ (1990): Primary prevention of neural tube defects with folic acid supplementation: Cuban Experience. Prenat. Diagnos. 10, 149-152.
106. Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok RJ, Hennekes CH & Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am. J. Epidemiol 143, 845-859.
107. Wald NJ & Bower C (1994): Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet. 343, 307.
108. Werler MM, Shapiro S & Mitchell AA (1993): Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269, 1257-1261.
109. Winship KA, Cahal DA, Weber JC & Griffin JP (1984): Maternal drug histories and central nervous system anomalies. Arch. Dis. Child. 59, 1052-1060.
110. Wu A, Chanarin I, Slavin G & Levi AJ (1975): Folate deficiency in the alcoholic - its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br. J. Haematol. 29, 469-478.
111. Yates JRW, Ferguson-Smith MA, Guzman-Rodriquez R, White M & Clark BJ (1987): Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin. Genet. 31, 279-287.
112. Zalunsky R & Herbert V (1961): Megaloblastic anaemia in scurvy with response to 50 microgram of folic acid daily. N. Engl. J. Med. 265, 1033-1038.